Maria H Gilleece
12PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|May 13, 2021
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.Maria H Gilleece, Avichai Shimoni, Myriam Labopin
|Dec 29, 2020
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia.Charles Craddock, Aimee Jackson, Justin Loke
|Sep 15, 2020
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.Adrian J C Bloor, Amit Patel, James E Griffin
|Jul 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT.Arnon Nagler, Frédéric Baron, Myriam Labopin
|Jul 01, 2020
A stitch in time saves nine… MRD-based pre-emptive therapy.Maria H Gilleece, Bipin N Savani
|Jun 13, 2020
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.Eolia Brissot, Myriam Labopin, Frédéric Baron
Pageof 2
Frequent Collaborators
5 joint publications
Bipin N Savani
4 joint publications
Jamie Sanz
4 joint publications
Jenny Byrne
3 joint publications
Alexandros Spyridonidis
3 joint publications
Didier Blaise
3 joint publications
Gerard Socié
2 joint publications
Florent Malard
2 joint publications
Frédéric Baron
1 joint publications
Matthew Collin
1 joint publications
John Gribben
